Encevra Research Round 48: Extract First, or Brief First?
Round 48 (IRE-48) of the Encevra Research program. Separates condition level cure discharge from record supersession, requires an independent reviewer to extract and provisionally decide from the packet before seeing any brief, and adds a dual domain track of authored clinical protocol amendment packets outside contracts and SEC exhibits, alongside 24 new public filing exhibits. Web version: https://research.encevra.com/round-48
Authors
- Ben Wilkins (ORCID: https://orcid.org/0009-0005-6532-3200)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-06
- DOI
- https://doi.org/10.5281/zenodo.24009035
- Primary Topic
- Pharmaceutical industry and healthcare
- Type
- preprint